Craig Aarts

The chimeric TAC receptor co-opts the T cell receptor yielding robust anti-tumor activity without toxicity

Christopher W. Helsen, Joanne A. Hammill, Vivian Wing Chong Lau et al. · Nature Communications · 2018 · 123 citations · Full text

Life Sciences, Immunology, Oncology +17

Ex vivo expanded natural killer cells from breast cancer patients and healthy donors are highly cytotoxic against breast cancer cell lines and patient-derived tumours

Mira M. Shenouda, Amy Gillgrass, Tina Nham et al. · Breast Cancer Research · 2017 · 79 citations · Full text

Life Sciences, Immunology, Oncology +17

Serotonergic system antagonists target breast tumor initiating cells and synergize with chemotherapy to shrink human breast tumor xenografts

William D. Gwynne, Robin Hallett, Adele Girgis-Gabardo et al. · Oncotarget · 2017 · 52 citations · Full text

Medicine, Oncology, Pharmacology +13

Kaiso depletion attenuates the growth and survival of triple negative breast cancer cells

Blessing Bassey‐Archibong, Lyndsay G. A. Rayner, Shawn M. Hercules et al. · Cell Death and Disease · 2017 · 34 citations · Full text

Medicine, Cell Biology, Oncology +17

Antagonists of the serotonin receptor 5A target human breast tumor initiating cells

William D. Gwynne, Mirza S. Shakeel, Adele Girgis-Gabardo et al. · BMC Cancer · 2020 · 20 citations · Full text

Medicine, Oncology, Pharmacology +16